FAPs activated by denervation or other pathological conditions such as spinal muscular atrophy (SMA) or amyotrophic lateral sclerosis (ALS) exhibited increased Stat3–IL6 signaling, which promoted muscle atrophy and fibrosis. The gene discussed is IL6; the disease is amyotrophic lateral sclerosis.